This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

GCS-100 in Combination with R-ICE in Relapsed or Refractory DLBCL

  • Research type

    Research Study

  • Full title

    A Phase 2 Study of GCS-100 in Combination with Chemo-immunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Protocol Number: PR-CS011

  • Contact name

    Rebecca Auer

  • Contact email

    r.l.auer@qmul.ac.uk

  • Sponsor organisation

    Prospect Therapeutics, Inc.

  • Eudract number

    2008-004087-40

  • ISRCTN Number

    ISRCTN66315383

  • Clinicaltrials.gov Identifier

    NCT

  • REC name

    London - Central Research Ethics Committee

  • REC reference

    08/H0718/57

  • Date of REC Opinion

    6 Oct 2008

  • REC opinion

    Further Information Favourable Opinion